Format

Send to

Choose Destination
Neurosci Biobehav Rev. 2013 Nov;37(9 Pt A):2081-6. doi: 10.1016/j.neubiorev.2013.05.002. Epub 2013 May 13.

Using conditioned place preference to identify relapse prevention medications.

Author information

1
Department of Pharmacology and Center for Compulsive Behaviors and Addiction, Rush University, Chicago, IL, United States. Electronic address: celeste_napier@rush.edu.

Abstract

Stimuli, including contexts, which predict the availability or onset of a drug effect, can acquire conditioned incentive motivational properties. These conditioned properties endure after withdrawal, and can promote drug-seeking which may result in relapse. Conditioned place preference (CPP) assesses the associations between drugs and the context in which they are experienced. Here, we review the potential utility of CPP procedures in rodents and humans to evaluate medications that target conditioned drug-seeking responses. We discuss the translational potential of the CPP procedure from rodents to humans, and review findings with FDA-approved treatments that support the use of CPP to develop relapse-reduction medications. We also discuss challenges and methodological questions in applying the CPP procedure to this purpose. We argue that an efficient and valid CPP procedure in humans may reduce the burden of full clinical trials with drug-abusing patients that are currently required for testing promising treatments.

KEYWORDS:

Addiction therapy; Amphetamine; Baclofen; Conditioned place preference; Humans; Methamphetamine; Mirtazapine; Naltrexone; Rodents; Varenicline

PMID:
23680702
PMCID:
PMC3815959
DOI:
10.1016/j.neubiorev.2013.05.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center